Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06348082 · ClinicalTrials.gov registry record · NA
Project Women's Insomnia Sleep Health Equity Study (WISHES)
A NA study of Insomnia and Cardiometabolic Health, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 340
- Enrollment target
- 2
- Study locations
NCT06348082: Recruiting NA study of Insomnia and Cardiometabolic Health, sponsored by Yale University.
NCT06348082 is a NA study of Insomnia and Cardiometabolic Health that is actively recruiting participants, run by Yale University. The registered enrollment target is 340 participants, above the 168-participant average among 151 other Insomnia trials with a reported enrollment target (102% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06348082, a NA study of Insomnia and Cardiometabolic Health, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 340 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to achieve health and healthcare equity by implementing an equity-focused, mindfulness-based sleep intervention to reduce stress and sleep deficiency-related cardiometabolic disease burden in Black women.
Primary Outcome
Change in Insomnia severity or remission will be assessed using the Insomnia Severity Index (ISI). The ISI is a 7 item survey used to determine insomnia severity. Total score range from 0-28 with cutoffs as follows: no insomnia (0-7), sub-threshold insomnia (8-14), moderate insomnia (15-21), and severe insomnia (22-28). Response to the MBTI on the ISI will be defined as a meaningful change of 7 or more points from baseline, or remission as reduction to a score less than 8.
Conditions Studied
Interventions
- BEHAVIORAL Mindfulness-based therapy for insomnia (MBTI)
Study Locations (2)
Connecticut
- Yale School of Nursing - New Haven
- Yale School of Nursing Biobehavioral Lab - West Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 340 participants |
| Start Date | 2026-01-06 |
| Est. Completion | 2028-08-31 |
| Phase | NA |
What NCT06348082 shows while recruiting
NCT06348082 is an interventional study that assigns participants to a tested intervention. The registered 340 participants enrollment target is mid-sized for trials with a published cap, above the 168-participant average among 151 other Insomnia trials with a reported enrollment target (102% higher).
The record links to 3 conditions, with Insomnia appearing as the primary indexed condition, and to 1 intervention - of which Mindfulness-based therapy for insomnia (MBTI) is the first listed.
NCT06348082 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT06348082 about?
NCT06348082 is a clinical study titled "Project Women's Insomnia Sleep Health Equity Study (WISHES)". The purpose of this study is to achieve health and healthcare equity by implementing an equity-focused, mindfulness-based sleep intervention to reduce stress and sleep deficiency-related cardiometabolic disease burden in Black women.
What is the current status of trial NCT06348082?
This trial is currently recruiting. It is a NA study. The enrollment target is 340 participants. The study started on 2026-01-06. Estimated completion is 2028-08-31.
What conditions does trial NCT06348082 study?
This clinical trial studies the following conditions: Insomnia, Cardiometabolic Health, Sleep Health.
What interventions are being tested in trial NCT06348082?
The interventions under investigation include: Mindfulness-based therapy for insomnia (MBTI) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06348082?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06348082 being conducted?
This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06348082's enrollment target sits among peer trials
340 20th of 151 higher than 132 of 151 other Insomnia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
mPATH for Low-income Older Adults
RECRUITING · NA
-
Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD
RECRUITING · NA
-
Adapted CBT-I for Adolescents With Insomnia : The DREAM-IT Study
RECRUITING · NA
-
Treatments in Women Veterans With Insomnia and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04176172 · 340 participants · Phase 3
Optimizing Tobacco Use Treatment for PLWHA
- NCT04545424 · 340 participants · Phase 2
Trial of Therapeutic Hypothermia in Patients With ARDS
- NCT04806958 · 340 participants · NA
The PulsePoint Study
- NCT05323409 · 340 participants · NA
Improving Comprehensive Care of Cancer Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI